Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia

ConclusionThe CTI can predict the short- and long-term survival of patients with cancer cachexia and provide a useful prognostic tool for clinical practice.

http://link.springer.com/10.1186/s40170-024-00332-8

Source: Cancer and Metabolism - January 25, 2024 Category: Cancer & Oncology Source Type: research